A Phase 1, Fixed Sequence, Cross-Over Study To Estimate The Effect Of Multiple Doses Of Ketoconazole On The Single Dose Pharmacokinetics Of Crizotinib (PF-02341066) In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 May 2013
At a glance
- Drugs Crizotinib (Primary) ; Ketoconazole
- Indications Cancer; Non-small cell lung cancer
- Focus Pharmacokinetics
- 17 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Jun 2010 New trial record